Dogwood Therapeutics, Inc. financial data

Symbol
DWTX on Nasdaq
Location
44 Milton Avenue, Alpharetta, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 587 % -30.9%
Debt-to-equity 1.25K % +9248%
Return On Equity -2.07K % -1485%
Return On Assets -34.1 % +70.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.91M shares -93.1%
Common Stock, Shares, Outstanding 1.91M shares -93.1%
Entity Public Float 5.76M USD -76.4%
Common Stock, Value, Issued 191 USD -93.1%
Weighted Average Number of Shares Outstanding, Basic 1.91M shares +109%
Weighted Average Number of Shares Outstanding, Diluted 1.91M shares +109%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.86M USD +481%
General and Administrative Expense 10.3M USD +200%
Operating Income (Loss) -18.2M USD -279%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24.6M USD -425%
Net Income (Loss) Attributable to Parent -24.7M USD -429%
Earnings Per Share, Basic -20 USD/shares -107%
Earnings Per Share, Diluted -20 USD/shares -107%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.4M USD +344%
Assets, Current 14.7M USD +304%
Property, Plant and Equipment, Net 16.2K USD
Operating Lease, Right-of-Use Asset 191K USD
Intangible Assets, Net (Excluding Goodwill) 69.3M USD
Goodwill 12.5M USD
Assets 96.7M USD +2559%
Accounts Payable, Current 498K USD +129%
Employee-related Liabilities, Current 496K USD
Accrued Liabilities, Current 1.33M USD +372%
Liabilities, Current 1.89M USD +277%
Deferred Income Tax Liabilities, Net 12.1M USD
Operating Lease, Liability, Noncurrent 132K USD
Other Liabilities, Noncurrent 15.4M USD
Liabilities 14.2M USD +2730%
Accumulated Other Comprehensive Income (Loss), Net of Tax -267K USD
Retained Earnings (Accumulated Deficit) -88.6M USD -38.8%
Stockholders' Equity Attributable to Parent 6.88M USD +119%
Liabilities and Equity 96.7M USD +2559%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.68M USD -400%
Net Cash Provided by (Used in) Financing Activities 7.37M USD
Common Stock, Shares Authorized 43M shares 0%
Common Stock, Shares, Issued 1.92M shares -93.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.4M USD +344%
Deferred Tax Assets, Valuation Allowance 31.4M USD +216%
Deferred Tax Assets, Gross 38.3M USD +277%
Operating Lease, Liability 187K USD
Depreciation 17K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -273K USD +74%
Lessee, Operating Lease, Liability, to be Paid 210K USD
Property, Plant and Equipment, Gross 19.4K USD
Operating Lease, Liability, Current 54.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 69.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 68K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Income Tax Expense (Benefit) 149 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.3K USD
Deferred Tax Assets, Operating Loss Carryforwards 26.1M USD +266%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares -0.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 41.8K USD
Operating Lease, Payments 32.2K USD
Additional Paid in Capital 71M USD +5.59%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.9M USD +3102%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%